GTBPVSHCA• 28 Days (Normalized)
GTBP vs HCA (GT Biopharma Inc. vs HCA Healthcare Inc.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+2.01%
GT Biopharma Inc.
Normalized Baseline0.00%
HCA Performance $426.69
+6.14%
HCA Healthcare Inc.
Normalized Baseline0.00%
Alpha Spread Margin HCA LEADS
-4.13 pts
HCA outperforming by 4.13 percentage points
GTBPHCA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP HCA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | GTBP Price | GTBP Gain (%) | HCA Price | HCA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +2.01% | $426.69 | +6.14% | -4.13% |
| Sep 30, 2026 | $- | $430.43 | +7.07% | - | |
| Sep 29, 2026 | $6.88 | +14.97% | $431.63 | +7.37% | +7.60% |
| Sep 28, 2026 | $6.80 | +13.71% | $432.60 | +7.61% | +6.10% |
| Sep 25, 2026 | $6.89 | +15.22% | $435.61 | +8.36% | +6.86% |
| Sep 24, 2026 | $6.83 | +14.21% | $423.48 | +5.34% | +8.87% |
| Sep 23, 2026 | $7.10 | +18.73% | $436.48 | +8.57% | +10.16% |
| Sep 22, 2026 | $- | $438.12 | +8.98% | - | |
| Sep 21, 2026 | $7.18 | +20.07% | $425.97 | +5.96% | +14.11% |
| Sep 18, 2026 | $7.16 | +19.73% | $427.71 | +6.39% | +13.34% |
| Sep 17, 2026 | $7.49 | +25.25% | $429.04 | +6.72% | +18.53% |
| Sep 16, 2026 | $7.81 | +30.60% | $430.43 | +7.07% | +23.53% |
| Sep 15, 2026 | $9.00 | +50.50% | $423.82 | +5.42% | +45.08% |
| Sep 14, 2026 | $11.63 | +94.48% | $425.49 | +5.84% | +88.64% |
| Sep 11, 2026 | $8.61 | +43.98% | $426.94 | +6.20% | +37.78% |
Page 1 of 2